These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12102440)

  • 21. Peripheral artery disease: therapeutic advances.
    Shamoun F; Sural N; Abela G
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):539-53. PubMed ID: 18402543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of risk in peripheral artery disease: recent therapeutic advances.
    Hackam DG; Goodman SG; Anand SS
    Am Heart J; 2005 Jul; 150(1):35-40. PubMed ID: 16084148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events.
    Coppola G; Novo S
    Arch Med Res; 2007 Jul; 38(5):479-88. PubMed ID: 17560452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral arterial disease as global vascular risk factor.
    Cimminiello C
    Haematologica; 2001 Nov; 86(11 Suppl 2):16-8. PubMed ID: 11926766
    [No Abstract]   [Full Text] [Related]  

  • 25. Hyperhomocysteinemia: marker of systemic atherosclerosis in peripheral arterial disease.
    Taute BM; Taute R; Heins S; Behrmann C; Podhaisky H
    Int Angiol; 2004 Mar; 23(1):35-40. PubMed ID: 15156128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease.
    Sigvant B; Wiberg-Hedman K; Bergqvist D; Rolandsson O; Wahlberg E
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):39-46. PubMed ID: 19237996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes.
    Lange S; Diehm C; Darius H; Haberl R; Allenberg JR; Pittrow D; Schuster A; von Stritzky B; Tepohl G; Trampisch HJ
    Exp Clin Endocrinol Diabetes; 2004 Nov; 112(10):566-73. PubMed ID: 15578331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of peripheral arterial disease in chronic kidney disease.
    O'Hare AM
    Cardiol Clin; 2005 Aug; 23(3):225-36. PubMed ID: 16084274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rational connection of inflammation with peripheral arterial disease.
    Li J; Li JJ; Li Q; Li Z; Qian HY
    Med Hypotheses; 2007; 69(6):1190-5. PubMed ID: 17555883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endovascular treatment of peripheral vascular disease.
    Allaqaband S; Kirvaitis R; Jan F; Bajwa T
    Curr Probl Cardiol; 2009 Sep; 34(9):359-476. PubMed ID: 19664498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of peripheral artery disease in urban high-risk Malaysian patients.
    Amudha K; Chee KH; Tan KS; Tan CT; Lang CC
    Int J Clin Pract; 2003 Jun; 57(5):369-72. PubMed ID: 12846339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary, peripheral and cerebrovascular disease: a complex relationship.
    Shah AM; Banerjee T; Mukherjee D
    Herz; 2008 Nov; 33(7):475-80. PubMed ID: 19066743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease.
    Blinc A; Poredos P
    Eur J Clin Invest; 2007 Mar; 37(3):157-64. PubMed ID: 17359482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting.
    Aboyans V; Lacroix P; Postil A; Guilloux J; Rollé F; Cornu E; Laskar M
    J Am Coll Cardiol; 2005 Sep; 46(5):815-20. PubMed ID: 16139130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
    Mohler ER
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S1-6. PubMed ID: 19213065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of dyslipidemia with statins in the patient with peripheral arterial disease.
    Blum AS
    Tech Vasc Interv Radiol; 2006 Jun; 9(2):50-5. PubMed ID: 17482100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral arterial disease: a guide for nephrologists.
    DeLoach SS; Mohler ER
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):839-46. PubMed ID: 17699501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral arterial disease in patients with diabetes.
    Marso SP; Hiatt WR
    J Am Coll Cardiol; 2006 Mar; 47(5):921-9. PubMed ID: 16516072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Underrecognized peripheral arterial disease in patients with acute coronary syndrome: prevalence of traditional and emergent cardiovascular risk factors].
    Huelmos A; Jiménez J; Guijarro C; Belinchón JC; Puras E; Sánchez C; Casas ML; López-Bescos L
    Rev Esp Cardiol; 2005 Dec; 58(12):1403-10. PubMed ID: 16371199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials.
    WAVE Investigators
    Am Heart J; 2006 Jan; 151(1):1-9. PubMed ID: 16368284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.